Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:24 PM
Ignite Modification Date:
2025-12-26 @ 5:24 PM
NCT ID:
NCT03480906
Eligibility Criteria:
Inclusion Criteria:
* Healthy patients without significant ocular pathology and mean unmedicated diurnal intraocular pressure (IOP) in the range of of 17-27 mmHg
* Willing to forego use of contact lenses during study period
* Presence of cognition an dexterity necessary to follow MiDD drug administration instructions
* Female subjects must be 1-year postmenopausal, surgically sterilized, or if of childbearing potential, have a negative serum pregnancy test
Exclusion Criteria:
* Prior clinically significant ocular history or abnormal eye exam
* Use of ocular medication within 30 days of screening
* Use of oral steroid within 30 days of screening, or anticipated need for ocular steroid treatment during study period
* History of drug or alcohol abuse within 1 year of screening
* Lid squeezer
* Presence of disabling arthritis or limited motor coordination that would limit self-handling of the MiDD
* Participation in any interventional study of an investigational drug or device within 30 days of screening
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03480906
Study Brief:
Protocol Section:
NCT03480906